CompaniesBraintree Labs

Braintree Labs

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

72

By Phase

PHASE2: 2

By Status

TERMINATED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT03062449
NCT03580616
Hover over trial bars to see details

Recent Trials

NCT03580616Collaborator
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)
PHASE2Terminated
43 participants
Started: Oct 24, 2018 · Completed: Dec 20, 2022
NCT03062449Collaborator
Phase IIa L-serine Trial for eAD
PHASE2Terminated
29 participants
Started: Mar 1, 2017 · Completed: Jul 20, 2021